BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3672368)

  • 1. [Effect of fructose-1,6-diphosphate and trental on the erythrocyte aggregating capacity in ischemic heart disease].
    Badalian GO; Episkoposian NG; Amatuni GV
    Ter Arkh; 1987; 59(7):92-5. PubMed ID: 3672368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improved cardiac performance with fructose-1,6-diphosphate in patients with ischemic heart disease].
    Lureti FG; Poggi Longostrevi G
    Riv Eur Sci Med Farmacol; 1988 Dec; 10(6):479-85. PubMed ID: 3274730
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of fructose-1,6-diphosphate in patients with chronic ischemic heart disease. Echocardiographic study].
    Pasotti C; Nicrosini S; Fiori G
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):315-20. PubMed ID: 2640054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a course of pentoxifylline (trental) treatment on microcirculatory and central hemodynamic functions in chronic ischemic heart disease patients].
    Atroshchenko ES
    Ter Arkh; 1985; 57(1):43-6. PubMed ID: 3983842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic assessment of anti-angina preparations in treating patients with ischemic heart disease with hypertension].
    Iunusov RA; Burykh LN; Sviridova NI
    Vrach Delo; 1987 Aug; (8):25-7. PubMed ID: 3686955
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of pentoxifylline in patients with stable angina pectoris.
    Insel J; Halle AA; Mirvis DM
    Angiology; 1988 Jun; 39(6):514-9. PubMed ID: 3377271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved exercise tolerance by i.v. fructose-1,6-diphosphate in chronic, stable angina pectoris.
    Marchionni N; Moschi G; Di Bari M; Ferrucci L; Paoletti M; Salani B; Fattirolli F
    J Clin Pharmacol; 1988 Sep; 28(9):807-11. PubMed ID: 3230148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pentoxifylline on platelet aggregation.
    Nenci GG; Gresele P; Agnelli G; Ballatori E
    Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the preparation trental in artificial circulation].
    Soboleva ER; Samsonova NN
    Anesteziol Reanimatol; 1986; (5):64-6. PubMed ID: 3492944
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the effect of fructose-1,6-diphosphate in orthopedic surgical patients].
    Urso L; Brillante C; Orlandi M; Ballati S
    Minerva Anestesiol; 1982 Nov; 48(11):819-21. PubMed ID: 7162660
    [No Abstract]   [Full Text] [Related]  

  • 11. [The characteristics of the cardioprotective action of fructose-1,6-diphosphate].
    Sernov LN; Rozonov IuB; Sokolova OA; Shal'neva TV; Snegireva GV; Gatsura VV
    Biull Eksp Biol Med; 1991 Feb; 111(2):172-3. PubMed ID: 1854962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of hemosorption and the separate and combined use of obsidan, trental and colpharit on rheological and hemostatic properties of the blood in patients with unstable stenocardia].
    Dmitriev AA; Khishtovani AI; Iakunin GA; Kormer AIa
    Ter Arkh; 1986; 58(5):68-73. PubMed ID: 3738796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood rheological effects in ischemic heart disease treated with antianginal and thrombolytic agents].
    Savenkov MP; Volov NA; Tebloev KI
    Kardiologiia; 1981 Aug; 21(8):63-9. PubMed ID: 7289386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute changes in global and regional systolic heart function caused by pentoxifylline in patients with and without coronary sclerosis].
    Franz N; Linss G; Modersohn D; Richter K; Lange T
    Z Gesamte Inn Med; 1988 May; 43(9):238-42. PubMed ID: 3407238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of beneficial effect of pentoxifylline on persistent forms of arterial hypertension.
    Mchedlishvili G; Tsinamdzvrihvili B; Momtselidze N; Beritashvili N
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):285-90. PubMed ID: 9741669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of fructose-1,6-diphosphate on the size of the necrotic area and course of the acute period of experimental myocardial infarction in rats].
    Sernov LN; Snegireva GV; Gatsura VV
    Kardiologiia; 1989 Aug; 29(8):66-9. PubMed ID: 2585964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of fructose-1,6-diphosphate sodium salt (FDP) in burnt patients.
    De Renzis A; Callegaris G; Vasi R
    Agressologie; 1982 Dec; 23(7):321-3. PubMed ID: 6762826
    [No Abstract]   [Full Text] [Related]  

  • 18. [The antiaggregant activity of the synthetic antioxidant emoxipin].
    Stoliarov VA; Repin AN; Markov VA
    Eksp Klin Farmakol; 1993; 56(2):35-6. PubMed ID: 8348036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of acetylsalicylic acid and pentoxifylline (trental) on intravascular erythrocyte aggregation stimulated by arachidonic acid].
    Sheremet'ev IuA; Shtykhno IuM; Udovichenko VI; Levin GIa
    Biull Eksp Biol Med; 1980 Sep; 90(9):276-9. PubMed ID: 7426725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions. Preliminary results.
    Schneider R; Schmid-Schönbein H; Kiesewetter H
    Eur Neurol; 1983; 22 Suppl 1():98-104. PubMed ID: 6884407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.